Norcomed is a Beijing biotechnology company that produces consumables for minimally invasive orthopedic spine surgery.
Established in 2013 and based in Beijing, China, Norcomed makes consumables for minimally invasive orthopedic spine surgery, including a spinal surgery access system and a disposable laparotomy tube. Its core research team comes from PLA General Hospital and Tsinghua University, and it is developing 3D-printed products for orthopedic endosseous plants. The company is at the Series A stage and closed its series A round in May 2018 with funding from Bison Capital, GSR United Management and Lenovo Venture Capital Group.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in